Skip to main content

Table 4 Clinical and pathological characteristics of pre-chemotherapy cluster B immune cell profile

From: Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer

Characteristic   Profile A and C % Profile B % P2)
Age <50 years 86 13 0.21
≥50 years 73 27  
HER2 Negative 81 19 0.19
Positive 66 33  
Hormone- sensitivity No 64 36 0.06
Yes 83 17  
IHC subtype HR+/HER2- 84 16 0.15
HR+/HER+ 82 18  
HR-/HER2+ 50 50  
HR-/HER2- 73 27  
Grade G1-2 87 13 0.03
G3 65 35  
cN cN0-1 81 19 0.24
cN2-3 69 31  
cT cT1-2 77 23 0.95
cT3-4 77 23  
  1. HER2, human epidermal growth factor receptor 2; HR, hormone receptor; IHC, immunohistochemistry.